ArticleNagoya journal of medical science2024

Thyroid autoantibodies at baseline predict longer survival in non-small cell lung cancer patients treated with anti-programmed cell death-1 blockade: a prospective study.

Takayuki Okuji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.